Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers
Clinical trial NCT06889350 · COMPLETED
Trial details
- NCT number
- NCT06889350
- Sponsor
- Handok Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-26
- Primary completion
- 2025-04-13
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.